Home

Fletcher Payne

CIK 1650476 · Sr VP and CFO · last filed 2026-07-01

Fletcher Payne is a Sr VP and CFO who has filed 17 SEC Form 4 insider transactions across 2 companies since 2015. Across all open-market trades the lifetime net is +$26.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.9K

Companies

2

Total Filings

17

Lifetime Open-Market Net

$26.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Aptose Biosciences Inc. (APTO) Delisted Sr VP and CFO 244 $1.71 $417 $6.8K 4 2024-02-07
CBIO Chief Financial Officer 294 $16.64 $4.9K $20.0K 11 2019-08-12

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-01 — Disp (D) −244 -$420
2024-02-07 Aptose Biosciences Inc. (APTO) Delisted Grant (A) — $0 EDGAR
2023-01-23 Aptose Biosciences Inc. (APTO) Delisted Grant (A) +100,000 $0 EDGAR
2022-09-21 Aptose Biosciences Inc. (APTO) Delisted Buy (P) +10,000 $6.8K EDGAR
2022-06-28 Aptose Biosciences Inc. (APTO) Delisted Grant (A) — $0 EDGAR
2019-08-12 CBIO Grant (A) +1,180 $7.7K EDGAR
2019-02-13 CBIO Grant (A) +1,002 $7.1K EDGAR
2019-02-04 CBIO Exer (M) +1,503 $7.0K EDGAR
2019-01-28 CBIO Grant (A) — $0 EDGAR
2018-08-01 CBIO Grant (A) — $0 EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.